Literature DB >> 33479740

Phosphatidylserine and phosphatidylethanolamine regulate the structure and function of FVIIa and its interaction with soluble tissue factor.

Tanusree Sengupta1, Tilen Koklic2, Barry R Lentz3, Rinku Majumder4.   

Abstract

Cell membranes have important functions in many steps of the blood coagulation cascade, including the activation of factor X (FX) by the factor VIIa (FVIIa)-tissue factor (TF) complex (extrinsic Xase). FVIIa shares structural similarity with factor IXa (FIXa) and FXa. FIXa and FXa are regulated by binding to phosphatidylserine (PS)-containing membranes via their γ-carboxyglutamic acid-rich domain (Gla) and epidermal growth-factor (EGF) domains. Although FVIIa also has a Gla-rich region, its affinity for PS-containing membranes is much lower compared with that of FIXa and FXa. Research suggests that a more common endothelial cell lipid, phosphatidylethanolamine (PE), might augment the contribution of PS in FVIIa membrane-binding and proteolytic activity. We used soluble forms of PS and PE (1,2-dicaproyl-sn-glycero-3-phospho-l-serine (C6PS), 1,2-dicaproyl-sn-glycero-3-phospho-ethanolamine (C6PE)) to test the hypothesis that the two lipids bind to FVIIa jointly to promote FVIIa membrane binding and proteolytic activity. By equilibrium dialysis and tryptophan fluorescence, we found two sites on FVIIa that bound equally to C6PE and C6PS with Kd of ∼ 150-160 μM, however, deletion of Gla domain reduced the binding affinity. Binding of lipids occurred with greater affinity (Kd∼70-80 μM) when monitored by FVIIa proteolytic activity. Global fitting of all datasets indicated independent binding of two molecules of each lipid. The proteolytic activity of FVIIa increased by ∼50-100-fold in the presence of soluble TF (sTF) plus C6PS/C6PE. However, the proteolytic activity of Gla-deleted FVIIa in the presence of sTF was reduced drastically, suggesting the importance of Gla domain to maintain full proteolytic activity.
© 2021 The Author(s).

Entities:  

Keywords:  Blood coagulation; Factor VIIa; Factor X; Phosphatidylethanolamine; Phosphatidylserine; Soluble tissue factor

Mesh:

Substances:

Year:  2021        PMID: 33479740      PMCID: PMC7859323          DOI: 10.1042/BSR20204077

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  34 in total

Review 1.  A cell-based model of hemostasis.

Authors:  M Hoffman; D M Monroe
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

2.  The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor.

Authors:  B J Clarke; F A Ofosu; S Sridhara; R D Bona; F R Rickles; M A Blajchman
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

3.  Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation.

Authors:  Tilen Koklic; Rinku Majumder; Barry R Lentz
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

4.  Kinetics of coagulation factor X activation by platelet-bound factor IXa.

Authors:  R Rawala-Sheikh; S S Ahmad; B Ashby; P N Walsh
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

5.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.

Authors:  D W Banner; A D'Arcy; C Chène; F K Winkler; A Guha; W H Konigsberg; Y Nemerson; D Kirchhofer
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

Review 6.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

Review 7.  Tissue factor in coagulation: Which? Where? When?

Authors:  Saulius Butenas; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

8.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

9.  The evaluation of complex-dependent alterations in human factor VIIa.

Authors:  J H Lawson; S Butenas; K G Mann
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

10.  Role of the membrane surface in the activation of human coagulation factor X.

Authors:  S Krishnaswamy; K A Field; T S Edgington; J H Morrissey; K G Mann
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.